NCT06693128 2026-01-28Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric CancerRuijin HospitalPhase 2 Active not recruiting80 enrolled
NCT04208347 2026-01-23Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric CancerRuijin HospitalPhase 2/3 Active not recruiting580 enrolled